|
|
||||||||
1 Department of Fisheries and Oceans Canada, Central and Arctic Region, 501 University Crescent, Winnipeg, Manitoba, Canada R3T 2N6
2 National Center for Foreign Animal Disease, Canadian Food Inspection Agency, 1015 Arlington Street, Winnipeg, Manitoba, Canada R3E 3M4
3 Université de Montréal, Faculté de médecine vétérinaire, 3200 rue Sicotte, St-Hyacinthe, Québec, Canada J2S 7C9
4 Department of Fisheries and Oceans Canada, Maurice Lamontagne Institute, 850 route de la Mer, Mont-Joli, Quebec, Canada G5H 3Z4
5 Department of Medical Microbiology, University of Manitoba, Winnipeg, Manitoba, Canada R3E 0W3
6 Corresponding author (email: Ole.Nielsen{at}DFO-MPO.GC.CA)
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The purpose of this study was to test three cell lines (Vero, primary seal kidney, and Vero.DogSLAMtag), using samples taken from PDV experimentally infected ferrets (Mustela putorius furo), in order to develop a cell culture and isolation methodology useful in the study of marine mammal morbilliviruses. Additionally, fresh tissues from experimentally infected ferrets were used to develop and test RT-PCR methodologies in order to follow the clinical course of infection in experimentally infected ferrets. These methods could then be useful in the diagnosis of distemper infections in stranded marine mammals.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Two 8-week-old unvaccinated, neutered, male, domestic ferrets (Mustela putorius furo) were purchased from Marshall Farms (North Rose, New York, USA) and were housed in separate cages in a biocontainment level-2 certified facility.
Viruses
The Lederle strain of CDV, propagated in chicken embryos (VR-128), was purchased from the American Type Culture Collection (ATCC, Manassas, Virginia, USA) and propagated in Vero cells. Phocine distemper virus for the ferret inoculation was obtained from frozen (–80 C) seal tissues from the 1988 PDV epizootic in Europe (Visser et al., 1989) and consisted of a 0.5% (v/v) suspension of a pool of spleen, lung, and intestinal lymph nodes taken from three dead harbor seals (titer 4.8x104 plaque-forming units [pfu]/ml in Vero.Dog-SLAMtag cells). Dolphin morbillivirus and PMV were obtained from Padraig Duignan, Massey University, Palmerston North, New Zealand, and were originally isolated from striped dolphins (Stenella coeruleoalba) from the Mediterranean Sea and harbor porpoises (Phocoena phocoena) from the North Sea off the coast of Ireland (Barrett et al., 1993), and subsequently propagated in Vero cells.
Experimental infection
After a short period of acclimation, induction of anesthesia of both ferrets at 12 wk of age was carried out in a chamber containing 3% isoflurane delivered with medical grade oxygen at 2 l/min. Once anesthetized, they were maintained, by mask, with 1.5% isoflurane delivered with oxygen at 1 l/min. Baseline samples of blood from the saphenous vein, and swabs from the nose, mouth, penis, and anus, were taken and served as negative controls. Each ferret was inoculated with 0.4 ml of the PDV-containing tissue homogenate via the intranasal route, while under anesthesia, to prevent loss of the inoculum by sneezing. Every five days postinoculation (dpi), the ferrets were anesthetized and sampling was repeated.
Monitoring clinical course of distemper infection
After inoculation, the animals were monitored daily. The following observations were recorded: rectal temperature, respiration rate, heart rate, amount of food and water consumed, and activity level. The presence or absence of any of the following clinical signs of distemper was also noted: conjunctivitis; central nervous system signs (seizures); a chin rash typical of distemper; and generalized erythema. Both animals were weighed pre-inoculation, at 5 dpi and then daily, until euthanasia.
Sampling and determination of end point
Once ferrets were observed to be ill, by display of clinical signs of distemper and with increasing morbidity as assessed by a consulting veterinarian, the ferrets were anesthetized and sampled as indicated above, then euthanized by an intravenous overdose of sodium pentobarbital (100 mg/kg). Organs and tissues were then sampled at necropsy for histopathology, immunohistochemistry, RT-PCR analyses, and virus isolation.
Isolation of PDV
In vitro isolation of PDV was conducted using three cell lines. African green monkey kidney cells (Vero C1008), purchased from the American Type Culture Collection (ATCC) (CRL 1586), were propagated using standard cell culture methodologies. Primary seal kidney cells (PSK), obtained from a presumed healthy weaned 2-wk-old harp seal collected from the Gulf of St. Lawrence in March 2004 with a Fisheries and Oceans Canada scientific permit, were propagated using standard primary cell culture methodology (Chan and Hsuing, 1994). Vero.DogSLAMtag cell line, a stable transfected continuous cell line containing the morbillivirus cell receptor (CD150), as described by Seki et al. (2003), was donated by Yasuke Yanagi, Department of Virology, Kyushu University, Fukuoka, Japan. To ensure that all the Vero.DogSLAMtag cells were still transfected, the cells were grown in media containing 0.5 mg/ml of the antibiotic G418 (Sigma-Aldrich Canada Ltd., Mississauga, Ontario, Canada), prior to use as previously described (Seki et al., 2003).
Blood from the experimentally infected ferrets was collected in heparinized tubes, and peripheral blood lymphocytes (PBLs) were separated by differential centrifugation on a layer of lymphocyte separation medium (Mediatech, Herndon, Virginia, USA). The PBLs were washed twice in Minimal Essential Medium (MEM; HyClone Inc., Logan, Utah, USA) containing antibiotics (penicillin 200 International Units/ml and streptomycin 200 µg/ml), and the pelleted cells were resuspended in 1.0 ml of MEM plus antibiotics. Then, 0.5 ml of the cell suspension was inoculated onto drained, 80% confluent cultures of Vero and PSK cells grown in 25 cm2 tissue culture flasks (Corning Inc., Corning, New York, USA). Virus was allowed to adsorb for 1 hr at 37 C before 10 mls of fresh medium, containing 2% fetal calf serum (FCS;HyClone), was added. Uninoculated cells and PBLs from the ferrets harvested before inoculation with PDV seeded into separate tissue culture flasks, served as negative controls. Flasks containing the cocultured cells were incubated at 37 C, and the adherent cells were subcultured at a ratio of 1:2 every week, with replenishment with fresh media for at least 6 wk or until signs of the cytopathic effect (CPE) consistent with morbillivirus infection (rounding up of cells, giant cell formation and syncytia formation), was detected.
Samples of lung from the experimentally infected ferrets, obtained at necropsy, were homogenized to give a 10% w/v cell free suspension in MEM containing antibiotics as indicated above and gentamycin (50 µg/ml) (BioWhittaker Inc., Walkersville, Maryland, USA). An aliquot of 0.5 ml served as inoculum for each 25 cm2 tissue culture flask containing Vero and PSK cells. The remaining infected ferret lung homogenate was stored in sterile cryovials and held at –80 C. When Vero.Dog-SLAMtag cells became available, lung homogenate was thawed and again 0.5 ml aliquots were inoculated (undiluted) onto 25 cm2 tissue culture flasks (in triplicate) of Vero.-DogSLAMtag, PSK, and Vero cells. These lung-inoculated flasks were treated in the same way as the PBL inoculated flasks.
Plaque assay
The PSK, Vero, and Vero.DogSLAMtag cells were compared with respect to the time it took for countable plaques to form, and viral titers were determined using four species of morbilliviruses. The inoculum used to infect the ferrets was also assayed by this method. All cell lines were propagated in MEM containing 10% FCS and antibiotics. Cell-adapted strains of CDV, PDV, DMV, and PMV, that had been passaged at least five times in Vero cells, were assayed using a plaque assay method, as described by Wolf and Quimby (1973). Briefly, serial tenfold dilutions of each virus were prepared in MEM containing antibiotics. Aliquots containing 100 µl were placed centrally on duplicate cell monolayers grown in tissue culture dishes (60x15 mm) (Corning Inc., Corning, New York, USA). Virus was allowed to adsorb for 60 min at 37 C before the addition of agarose gel maintenance medium. Plates were then incubated at 37 C and observed daily for plaque development. When visible plaques were observed, plates were fixed with formaldehyde, the gels removed, cell sheets were stained with crystal violet staining solution, and the plaques were counted.
Collection and handling of samples for RT-PCR
Swabs were collected in 0.01 M phosphate buffered saline (PBS) containing double strength antibiotics, and 100 µl samples of whole blood from the ferrets were immediately transferred into tubes containing TriPure (Roche Diagnostics, Laval, Quebec, Canada), according to the manufacturers directions, and held frozen at –80 C until analysis. Supernatant fluid (100 µl samples) from Vero flasks infected with CDV, DMV, and PMV, that showed extensive CPE, were also transferred to tubes containing TriPure and held frozen at –80 C. A mock-infected flask containing only Vero cells was used as the negative control. Ferret PBL-infected flasks of Vero and PSK cells, incubated for at least 4 wk, were handled in the same way as the CDV, DMV, and PMV-infected flasks. The PDV passaged five times in Vero cells with a titer of 2.7x105 pfu/ml, determined by plaque assay in Vero cells, served as the positive control for all subsequent RT-PCR experiments. Tissue samples from the experimentally infected ferrets were homogenized using a bag system homogenizer (Interscience, Topac, Hingham, Massachusetts, USA), whereby each tissue was added to 0.01 M PBS containing penicillin/streptomycin (1 ml/0.1 g of tissue). After 3 min of homogenizing, the samples were clarified by low speed centrifugation at 2060 x G (700 rcf) for 10 min. The following tissue samples were used: spleen, stomach, pancreas, adrenal gland, small intestine, large intestine, lung, eye, liver, footpad, urinary bladder, tracheal and bronchial lymph nodes, spinal cord, conjunctiva, heart, thymus, trachea, and kidney.
RNA extraction
Samples (100 µl), prepared as described above, were combined with 900 µl of TriPure, and the RNA was extracted as per manufacturers instructions. The RNA pellet from each tube was then resuspended in 20 µl of RNASecure reagent (Ambion, Austin, Texas, USA) and stored at –70 C until further analysis.
RT-PCR assay
The primer set designated N-FOR/N-REV: N-FOR (5'-TCCCATCACCATGAAGTC-3', position 126–143); N-REV (5'-TGACTCGTCCCATTCAGA-3', position 223–240), was designed at the National Center for Foreign Animal Disease, Winnipeg, Manitoba, Canada. The RNA was transcribed and amplified using a One-Step RT-PCR kit (Qiagen, Mississauga, Ontario, Canada), with an initial 30-min incubation at 50 C for reverse transcription, followed by PCR cycle; 15 min incubation at 95 C; followed by 40 cycles with denaturation at 95 C for 30 sec; annealing at 58 C for 1 min; and an elongation step at 72 C for 2 min. A final elongation step of 10 min at 72 C was then performed. The expected product was 114 bp.
A previously tested primer set (Jensen et al., 2002) designated P1/P2, targeting the phosphoprotein gene of morbilliviruses, was also used: P1 sequence (5'-ATGTTTATGATCACAGCGGT-3', position 851–870); P2 sequence (5'-ATTGGGTTGCACCACTTGTC 3', position 1261–1280). The reaction components and conditions of using this primer set were the same as those for the N-FOR/N-REV RT-PCR; however, the annealing temperature in the RT-PCR procedure was 48 C. In addition, RT-PCR, using generic diagnostic beta-actin gene primers and probe, was used to confirm the integrity of the RNA extracted for use in conventional PCR. Specifically, the sequences were as follows: Beta actin 831 Forward (BTCCTTCCTGGGCATGGA); Beta actin 1036 Reverse (GRGGSGCGATGATCTTGAT); Beta actin Internal Probe 880-908 (TCCATCATGAAGTGYGACGTSGACATCCG)—5'TET labeled and 3' BHQ-1 labeled. The resulting product was 205 bp in length. The samples were run on the Smart-Cycler II (Cepheid, Roche Molecular Systems, Inc., USA). The beta-actin RNA was amplified using the Qiagen Quantitect Probe Real-time PCR kit (Qiagen, Mississauga, Ontario, Canada), under the following amplification conditions: 50 C for 30 min; 95 C for 15 min; 45 cycles of 95 C for 10 sec; followed by 60 C for 1 min. Amplification was monitored and analyzed using SmartCycler II software (Cepheid, Sunnydale, California, USA). Five positive RT-PCR products were sequenced using the N-FOR/N-REV primer set and were confirmed to contain amplified PDV sequence, thus confirming the specificity of the RT-PCR reaction for phocine distemper virus (data not shown).
Electrophoresis of RT-PCR products
All RT-PCR samples, derived from conventional PCR, were analyzed by 1% agarose gel electrophoresis (stained with 1 µg/ml of ethidium bromide) using 10 µl samples per lane and a running condition of 100 volts for 2 hr. A 100 bp standard (BioRad, Mississauga, Ontario, Canada) was used to track the mobility of RT-PCR products.
Evaluation of the sensitivity of the N-FOR/N-REV primer set in standard RT-PCR
The sensitivity of the N-FOR/N-REV primer set was done using 10-fold dilutions (from 13,500 50% tissue culture infectious doses [TCID50] to 135 TCID50) of Vero cell passaged CDV, PDV, PMV, or DMV stock virus.
Histopathology and immunohistochemistry
Organ samples were fixed in 10% neutral buffered formalin for 72 hr, before being embedded in paraffin using standard histologic methodology. Sections were cut at 5–6 µm and stained with hematoxylin, phloxine, and saffron for histopathologic analyses. Using an immunoperoxidase test for PDV, additional sections from the paraffin blocks were stained with a 1:10 and 1:20 dilution of PDV 1.3 monoclonal antibody obtained from Seamus Kennedy, Department of Agriculture for Northern Ireland, Belfast, Ireland, using methodology published by Kennedy et al. (1991). Brain tissue from a dog with distemper served as a positive control. Staining was positive, but weak, likely due to inadequate freezing of the monoclonal antibody during shipment; therefore, additional sections were stained with polyclonal antisera (developed against measles nucleoprotein at the University of Saskatchewan, Western College of Veterinary Medicine).
| RESULTS |
|---|
|
|
|---|
|
|
|
|
Histologic lesions, highly suggestive of infection with morbilliviruses, were observed in tissues from both ferrets 12 dpi. The most severe lesions were observed in the lungs, where multifocal to coalescing interstitial pneumonia with marked type II pneumocyte hyperplasia (Fig. 4A
), and a diffuse suppurative bronchiolitis, were noted. A marked and diffuse lymphoid depletion was also observed in the lymph nodes, thymus, and spleen of both ferrets. Other lesions were of low magnitude and included a mild ulcerative suppurative conjunctivitis (both ferrets), a mild multi-focal neuronal degeneration with mild focal cerebral gliosis (both ferrets), and a mild multifocal suppurative tracheitis (in one of the two ferrets). Acidophilic intracytoplasmic inclusions were easily observed in the epithelial lining of the bronchioles, the urothelial cells of the renal pelvis and urinary bladder (Fig. 4B
), the bile ducts, and the thymus. Immunohistochemical staining of fixed tissues indicated a fulminant infection, in both ferrets, with quite extensive morbillivirus-specific antigen staining in many tissues, primarily epithelium. Morbillivirus antigen was expressed extensively in airway and alveolar epithelium as well as alveolar macrophages; in basal epithelium of hair follicles of the eyelid; in focal areas of the epithelium of the footpad; in epithelium throughout the stomach and all strata of the villi (extensively in the colon and focally in the duodenum and jejunum); and in epithelium of the urinary bladder, pancreatic ducts, kidney, bile ducts in the liver and renal pelvis (Fig. 4C, D
). Sampled tissues from all major organs in both ferrets also tested positive for PDV using RT-PCR (Table 1
), supporting histologic findings.
|
|
| DISCUSSION |
|---|
|
|
|---|
The lesions observed in the infected ferrets are similar to lesions described in ferrets naturally and experimentally infected with CDV (Fox et al., 1998) and with seals naturally infected with PDV (Kennedy et al., 1989). The most prominent histologic changes were seen in the lung and lymphoid tissues. Suppurative infiltrates observed in the trachea, bronchioles, and conjunctiva were suggestive of secondary bacterial infection. The fact that the animals were euthanized only 12 dpi probably accounts for the absence of overt encephalitis and the relatively low number of inclusion bodies observed.
A significant finding was that PDV replication in ferrets and Vero.DogSLAM-tag cells progressed rapidly (days), whereas virus replication in PSK and Vero cells took much longer (weeks; Table 2
). Lymphoid tissues are the major sites of morbillivirus replication, and CD150 or "signaling lymphocyte activation molecules" (SLAM) have been identified as the cellular receptor for all morbilliviruses (Tatsuo et al., 2001). The Vero.Dog-SLAMtag cell line used in this study was stably transfected and expresses the canine SLAM molecule (Seki et al., 2003). Presumably, ferret PBLs and the Vero.-DogSLAMtag cells both possess similar cell receptors that allow attachment of PDV and subsequent rapid replication of the virus. Since Vero and PSK cells do not have SLAM receptors, PDV is likely infecting these cells by utilizing less-efficient cell receptors present on those cells. This may also account for the observation that PDV was detected, by RT-PCR, in tissues of nonlymphoid origin (brain and gastrointestinal tract) and in the gastrointestinal tract, using immunohistochemistry on infected ferret tissues. However, a further understanding of the distribution of SLAM receptors in ferrets, as well as the role that other virus receptors may have in the infection of nonlymphoid cells, is needed before these hypotheses can be proven.
PDV was identified from both ferrets using three techniques; namely, virus isolation in tissue culture, RT-PCR, and immunohistochemistry. While RT-PCR was able to detect PDV nucleic acid from swab samples taken from ferrets in as little as 5 dpi, viral isolation was also possible from blood samples (PBLs) collected at the same time. Viral isolation took considerably longer to accomplish (29 days using Vero cells and 22 days using PSK cells, versus 2 days by RT-PCR detection of nucleic acid). However, when Vero.Dog-SLAMtag cells were used for virus isolation, analysis times were similar. Virus isolation was possible with frozen lung homogenates using Vero.DogSLAMtag cells, but isolation was only possible in Vero cells from fresh material. One possible explanation for this result is that freezing of the lung homogenate may have reduced the titer of virus below the threshold of detection in Vero cells. Both viral isolation and RT-PCR have advantages and disadvantages for the detection of distemper infection in wildlife. Viral isolation is only possible from samples taken from moribund or freshly dead animals, while RT-PCR can be performed successfully on samples that have been degraded or compromised (Forsyth and Barrett, 1995). Viral isolation remains the "gold standard" for identification of distemper infection, and in vitro preparations of these isolates allow investigators to confirm results further by using both molecular and serologic technologies. With the identification of the CD 150 SLAM as the universal cell receptor molecule for morbillivirus attachment, the use of stably transfected cells containing these receptors can be useful in studies where viral isolation is used as a diagnostic tool on clinical samples. These cell lines require no special media or requirements above those found in most tissue culture laboratories. We have also shown that Vero cell-adapted isolates of CDV, PDV, DMV, and PMV are able to replicate faster, and to a higher final titer, in Vero.DogSLAMtag cells than in Vero cells, indicating that these isolates are able to recognise and bind SLAM cell receptors preferentially (see Table 2
). Use of SLAM rather than Vero cells, in serologic surveys of distemper in marine mammals, has also reduced analysis times of the plaque neutralization technique, thereby increasing efficiency and decreasing cost (Duignan et al., 1997). A possible explanation for the lower titers obtained when using Vero and PSK cells may be that morbilliviruses produced limited fusion in these cell types, and as a consequence, the final titers may be lower. Use of a vital stain, coupled with immunofluorescence, would be needed to confirm the actual titers in each cell line, but this is outside the scope of the present study. Although the SLAM cell line used in this study only possesses the cell receptor specific for canines, data reported here suggests that there is cross-reactivity between mustelid, canine, phocine, and cetacean SLAM receptors that allows efficient attachment of marine mammal morbilliviruses from a broad host range of animals.
The RT-PCR results in this study have shown that there are two sets of primers (one specific for the phosphoprotein gene and the other for the nucleocapsid gene) that can be used accurately in a clinical setting when testing swab, tissue, and blood samples. The nucleocapsid-specific primer set has also been shown to be specific only to PDV virus (see Fig. 2
), demonstrating a quick and accurate methodology for the detection of morbilliviruses and for differentiating PDV from other related morbilliviruses.
Results from this study indicate that it is possible to isolate and quickly identify morbilliviruses from stranded marine mammals. These advances in cell culture and RT-PCR methodologies will aid morbillivirus researchers in identifying new strains in terrestrial and marine hosts, as well as in providing a reliable cell culture system for viral propagation.
| ACKNOWLEDGMENTS |
|---|
| LITERATURE CITED |
|---|
|
|
|---|
———, AND O. R. JONES. 1967. Use of alveolar macrophages for cultivation of canine distemper virus. In Proceedings of the Society for Experimental Biology and Medicine 126: 571–574.
BARRETT, T., I. K. G. VISSER, L. MAMAEV, L. GOATLET, M.-F. VAN BRESSEM, AND A. D. M. E. OSTERHAUS. 1993. Dolphin and porpoise morbilliviruses are genetically distinct from phocine distemper virus. Virology 193: 1010–1012.[Medline]
CHAN, V. F., AND G. D. HSUING. 1994. Cell culture preparation. In Hsuings diagnostic virology as illustrated by light and electron microscopy, 4th Edition. Yale University Press, New Haven, Connecticut, USA, pp. 337–374.
DAOUST, P. Y., D. M. HAINES, J. THORSEN, P. J. DUIGNAN, AND J. R. GERACI. 1993. Phocine distemper in a harp seal (Phoca groenlandica) from the Gulf of St. Lawrence, Canada. Journal of Wildlife Diseases 29: 114–117.[Abstract]
DUIGNAN, P. J., S. SADOVE, J. T. SALIKI, AND J. R. GERACI. 1993. Phocine distemper in harbour seals (Phoca vitulina) from Long Island, New York. Journal of Wildlife Diseases 29: 465–469.[Abstract]
———, J. T. SALIKI, D. J. ST. AUBIN, J. A. HOUSE, AND J. R. GERACI. 1994. Neutralizing antibodies to phocine distemper virus in Atlantic walruses (Odobenus rosmarus rosmarus) from Arctic Canada. Journal of Wildlife Diseases 30: 90–94.[Abstract]
———, ———, ———, G. EARLY, S. SADOVE, J. A. HOUSE, E. K. KOVACS, AND J. R. GERACI. 1995. Epizootiology of morbillivirus infection in North American harbour seals (Phoca vitulina) and gray seals (Halichoerus grypus). Journal of Wildlife Diseases 31: 491–501.[Abstract]
———, O. NIELSEN, C. HOUSE, K. KOVACS, N. DUFFY, G. EARLY, S. SADOVE, D. J. ST. AUBIN, B. K. RIMA, AND J. R. GERACI. 1997. Epizootiology of morbillivirus infection in harp seals (Phoca groenlandica), hooded seals (Cystophora cristata), and ringed seals (Phoca hispida) from the Canadian Arctic and the western Atlantic. Journal of Wildlife Diseases 33: 7–19.[Abstract]
FORSYTH, M. A., AND T. BARRETT. 1995. Evaluation of polymerase chain reaction for the detection and characterization of rinderpest and peste des petits ruminants viruses for epidemiological studies. Virus Research 39: 151–163.[Medline]
FOX, J. G., C. R. PEARSON, AND J. R. GORHAM. 1998. Viral Diseases. In Biology and diseases of the ferret, 2nd Edition. Lippincott Williams and Wilkins, Baltimore, Maryland, pp. 355–374.
HENDERSON, G., A. TRUDGETT, C. LYONS, AND K. RONALD. 1992. Demonstration of antibodies in archived sera from Canadian seals reactive with a European isolate of phocine distemper virus. Science of the Total Environment 115: 93–98.[Medline]
JENSEN, T., M. VAN DE BILDT, H. H. DIETZ, T. H. ANDERSON, A. S. HAMMER, T. KUIKEN, AND A. OSTERHAUS. 2002. Another phocine distemper outbreak in Europe. Science 297: 209.
KENNEDY, S., J. A. SMYTH, S. J. MCCULLOUGH, G. M. ALLAN, F. MCNEILLY, AND D. S. MCQUAID. 1988. Confirmation of cause of recent seal deaths. Nature 335: 404.[Medline]
———, ———, P. F. CUSH, P. DUIGNAN, M. PLATTEN, S. J. MCCULLOUGH, AND G. M. ALLAN. 1989. Histopathologic and immunocytochemical studies of distemper in seals. Veterinary Pathology 26(2): 97–103.[Abstract]
———, ———, ———, M. MCALISKEY, S. J. MCCULLOUGH, AND B. K. RIMA. 1991. Histopathologic and immunocytochemical studies of distemper in harbour porpoises. Veterinary Pathology 28: 1–7.[Abstract]
NIELSEN, O., R. E. A. STEWART, L. MEASURES, P. DUIGNAN, AND C. HOUSE. 2000. A morbillivirus antibody survey of Atlantic walrus, narwhal and beluga in Canada. Journal of Wildlife Diseases 36: 508–517.[Abstract]
OSTERHAUS, A. D. M. E., AND E. J. VEDDER. 1988. Identification of virus causing seal deaths. Nature 335: 20.[Medline]
———, ———, J. GROEN, P. DEVRIES, F. G. C. M. UYTDHAAG, B. KLINGBORN, AND R. ZARNKE. 1988. Canine distemper in seals. Nature 335: 403–404.[Medline]
———, ———, ———, H. NIESTERS, M. VAN DE BILT, B. MARTINA, L. VEDDER, J. VOS, H. VAN EGMOND, B. ABOU SIDI, AND M. ELY OULD BARHAM. 1997. Morbillivirus in monk seal mortality. Nature 388: 838–839.[Medline]
PHILIPPA, J. D. W., F. A. LEIGHTON, P. Y. DAOUST, O. NIELSEN, M. PAGLIARULO, H. SCHWANTJE, T. SHURY, R. VAN HERWUNEN, B. E. E. MARTINA, T. KUIKEN, M. W. G. VAN DE BILDT, AND A. D. M. E. OSTERHAUS. 2004. Antibodies to selected pathogens in free-ranging terrestrial carnivores and marine mammals in Canada. Veterinary Record 155: 135–140.
RIMA, B. K., A. M. J. COLLIN, AND J. A. P. EARLE. 2005. Completion of the sequence of a cetacean morbillivirus and comparative analysis of the complete genome sequences of four morbilliviruses. Virus Genes 30: 113–119.[Medline]
ROSS, P. S., I. K. G. VISSER, H. W. J. BROEDERS, M. W. G. VAN DE BILDT, W. D. BOWEN, AND A. D. M. E. OSTERHAUS. 1992. Antibodies to phocine distemper virus in Canadian seals. Veterinary Record 130: 514–516.[Medline]
SALIKI, J. T., E. J. COOPER, AND J. P. GUSTAVSON. 2002. Emerging morbillivirus infections of marine mammals. Annals of the New York Academy of Sciences 969: 51–59.[Medline]
SEKI, F., N. ONO, R. YAMAGUCHI, AND Y. YANAGI. 2003. Efficient isolation of wild strains of canine distemper viruses in Vero cell expressing canine SLAM (CD150) and their adaptability to marmoset B95a cells. Journal of Virology 77: 9943–9950.
STANTON, J. B., C. C. BROWN, S. POET, T. P. LIPSCOMB, J. SALIKI, AND S. FRASCA, JR. 2004. Retrospective differentiation of canine distemper virus and phocine distemper virus in phocids. Journal of Wildlife Diseases 40: 53–59.
TATSUO, H., N. ONO, AND Y. YANAGI. 2001. Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors. Journal of Virology 75: 5842–5850.
TAUBENBERGER, J. K., M. TSAI, A. E. KRAFT, J. H. LICHY, A. H. REID, R. Y. SCHULMAN, AND T. P. LIPSCOMB. 1996. Two morbilliviruses implicated in bottlenose dolphin epizootics. Emerging Infectious Diseases 2: 213–216.[Medline]
VISSER, I. K. G., M. W. G. VAN DE BILT, H. N. BRUGGE, P. J. H. REIJNDERS, E. J. VEDDER, J. KUIPER, P. DEVRIES, J. GROEN, H. C. WALVOORT, F. G. C. M. UYTDE HAAG, AND A. D. M. E. OSTERHAUS. 1989. Vaccination of harbour seals (Phoca vitulina) against phocid distemper virus (CDV) vaccines. Vaccine 7: 521–526.[Medline]
WOLF, K., AND M. C. QUIMBY. 1973. Fish viruses: Buffers and methods for plaquing eight agents under normal atmosphere. Applied Microbiology 25: 659–664.[Medline]
Received for publication 13 April 2007.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |